Thromb Haemost 2020; 120(02): 262-276
DOI: 10.1055/s-0039-3400295
Cellular Haemostasis and Platelets
Georg Thieme Verlag KG Stuttgart · New York

A Comprehensive Tyrosine Phosphoproteomic Analysis Reveals Novel Components of the Platelet CLEC-2 Signaling Cascade

Authors

  • Irene Izquierdo

    1   Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), Universidad de Santiago de Compostela, and Instituto de Investigación Sanitaria (IDIS), Santiago de Compostela, Spain
  • María N. Barrachina

    1   Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), Universidad de Santiago de Compostela, and Instituto de Investigación Sanitaria (IDIS), Santiago de Compostela, Spain
  • Lidia Hermida-Nogueira

    1   Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), Universidad de Santiago de Compostela, and Instituto de Investigación Sanitaria (IDIS), Santiago de Compostela, Spain
  • Vanessa Casas

    2   CSIC/UAB Proteomics Laboratory, Institute of Biomedical Research of Barcelona, Spanish National Research Council (IIBB-CSIC/IDIBAPS), Barcelona, Spain
  • Luis A. Morán

    1   Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), Universidad de Santiago de Compostela, and Instituto de Investigación Sanitaria (IDIS), Santiago de Compostela, Spain
  • Serena Lacerenza

    3   Department of Pharmacy, University of Pisa, Pisa, Italy
  • Roberto Pinto-Llorente

    2   CSIC/UAB Proteomics Laboratory, Institute of Biomedical Research of Barcelona, Spanish National Research Council (IIBB-CSIC/IDIBAPS), Barcelona, Spain
  • Johannes A. Eble

    4   Institute of Physiological Chemistry and Pathobiochemistry, University of Münster, Münster, Germany
  • Vivian de los Ríos

    5   Proteomics Facility, Centro de Investigaciones Biológicas (CIB-CSIC), Madrid, Spain
  • Eduardo Domínguez

    1   Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), Universidad de Santiago de Compostela, and Instituto de Investigación Sanitaria (IDIS), Santiago de Compostela, Spain
  • María I. Loza

    1   Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), Universidad de Santiago de Compostela, and Instituto de Investigación Sanitaria (IDIS), Santiago de Compostela, Spain
  • José Ignacio Casal

    5   Proteomics Facility, Centro de Investigaciones Biológicas (CIB-CSIC), Madrid, Spain
  • Montserrat Carrascal

    2   CSIC/UAB Proteomics Laboratory, Institute of Biomedical Research of Barcelona, Spanish National Research Council (IIBB-CSIC/IDIBAPS), Barcelona, Spain
  • Joaquín Abián

    2   CSIC/UAB Proteomics Laboratory, Institute of Biomedical Research of Barcelona, Spanish National Research Council (IIBB-CSIC/IDIBAPS), Barcelona, Spain
  • Angel García

    1   Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), Universidad de Santiago de Compostela, and Instituto de Investigación Sanitaria (IDIS), Santiago de Compostela, Spain

Funding This study was supported by the Spanish Ministry of Economy and Competitiveness (MINECO) [grant No. SAF2016-79662-R], co-funded by the European Regional Development Fund (ERDF); and the Consellería de Cultura, Educación e Ordenación Universitaria, Xunta de Galicia [ED431C 2018/21; predoctoral grant Plan I2C 2014; and Centro Singular de investigación de Galicia accreditation 2016-2019, ED431G/05], co-funded by the European Regional Development Fund (ERDF). The study also received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 766118. J.A.E. is supported by Deutsche Forschungsgemeinschaft [DFG grant: EB177/13-1].
Weitere Informationen

Publikationsverlauf

01. Juli 2019

08. Oktober 2019

Publikationsdatum:
04. Januar 2020 (online)

Preview

Abstract

C-type lectin-like receptor 2 (CLEC-2) plays a crucial role in different platelet-related physiological and pathological processes. It signals through a tyrosine kinase-mediated pathway that is highly dependent on the positive feedback exerted by the platelet-derived secondary mediators, adenosine diphosphate (ADP) and thromboxane A2 (TXA2). Here, we aimed to analyze the tyrosine phosphoproteome of platelets activated with the CLEC-2 agonist rhodocytin to identify relevant phosphorylated tyrosine residues (p-Tyr) and proteins involved in platelet activation downstream of this receptor. We identified 363 differentially p-Tyr residues, corresponding to the majority of proteins previously known to participate in CLEC-2 signaling and also novel ones, including adaptors (e.g., DAPP1, Dok1/3, CASS4, Nck1/2), kinases/phosphatases (e.g., FAK1, FES, FGR, JAK2, SHIP2), and membrane proteins (e.g., G6F, JAM-A, PECAM-1, TLT-1). To elucidate the contribution of ADP and TXA2 at different points of the CLEC-2 signaling cascade, we evaluated p-Tyr levels of residues identified in the analysis and known to be essential for the catalytic activity of kinases Syk(p-Tyr525+526) and Src(p-Tyr419), and for PLCγ2 activity (p-Tyr759). We demonstrated that Syk phosphorylation at Tyr525+526 also happens in the presence of ADP and TXA2 inhibitors, which is not the case for Src-pTyr419 and PLCγ2-pTyr759. Kinetics studies for the three phosphoproteins show some differences in the phosphorylation profile. Ca2+ mobilization assays confirmed the relevance of ADP and TXA2 for full CLEC-2-mediated platelet activation. The present study provides significant insights into the intracellular events that take place following CLEC-2 activation in platelets, contributing to elucidate in detail the CLEC-2 signalosome.

Authors' Contributions

I.I.: performed research, analyzed data, and wrote the paper. M.N.B., L.H.-N., V.C., L.A.M., S.L., R.P.-L., and V.d.l.R,: performed research. J.I.C., M.C., and J.A.: contributed with key analytical tools and analyzed and integrated mass spec data. J.A.E.: provided vital reagents. E.D. and M.I.L.: provided vital reagents and analytical tools for the calcium release experiments. A.G.: designed research, analyzed data, provided vital reagents and analytical tools, and wrote the paper.